Copyright
©2013 Baishideng Publishing Group Co.
Figure 5 Vitreal and retinal distribution of intravitreally administered.
A: Polyethyleneimine/glycol chitosan heterogeneous nanoparticles; B: Human serum albumin/glycol chitosan heterogeneous nanoparticles; C: Human serum albumin/ hyaluronic acid heterogeneous nanoparticles 6 h post-injection. Red color = FPR-552 conjugated nanoparticles, blue color = DAPI staining of retinal cell nuclei. VH: Vitreous; RE: Retina; ILM: Inner limiting membrane; INL: Inner nuclear layer; ONL: Outer nuclear layer, respectively. All images were captured at × 10 magnification. Reproduced with permission from reference Koo et al[66].
- Citation: Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: An overview. World J Pharmacol 2013; 2(2): 47-64
- URL: https://www.wjgnet.com/2220-3192/full/v2/i2/47.htm
- DOI: https://dx.doi.org/10.5497/wjp.v2.i2.47